ESPEROCT
antihemophilic factor (recombinant), glycopegylated-exei · KIT · Novo Nordisk
ESPEROCT is a kit containing antihemophilic factor (recombinant), glycopegylated-exei. Manufactured by Novo Nordisk.
Key Facts
- Brand Name
- ESPEROCT
- Generic Name
- antihemophilic factor (recombinant), glycopegylated-exei
- NDC Code (Product)
0169-8100- Manufacturer
- Novo Nordisk
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125671
- Marketing Start
- 02/19/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is ESPEROCT used for?
ESPEROCT contains antihemophilic factor (recombinant), glycopegylated-exei. It is a kit taken as directed. Consult your doctor for specific uses.
Is ESPEROCT a controlled substance?
ESPEROCT is not classified as a controlled substance by the DEA.
What is the generic name for ESPEROCT?
The generic name for ESPEROCT is antihemophilic factor (recombinant), glycopegylated-exei. There are no other listed brand versions of antihemophilic factor (recombinant), glycopegylated-exei.
What is the NDC code for ESPEROCT ?
The NDC (National Drug Code) for ESPEROCT is 0169-8100, listed by Novo Nordisk.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)